Cohance Lifesciences, Divi’s Laboratories, and SAI Life Sciences rallied after Jefferies initiated coverage with ‘Buy’ ratings, citing strong growth prospects in India’s CRDMO sector. The brokerage sees a high-teen revenue CAGR, led by China+1 diversification, pipeline visibility, and demand for diabetes and weight-loss therapies.
Dow, S&P 500 slip as oil hovers near $100 despite Nasdaq’s record close
The Dow and S&P 500 declined sharply as oil prices rallied near the $100 mark, causing apprehension among investors. However, the Nasdaq soared to a